MBIO
HEALTHCAREMustang Bio Inc
$0.75-0.03 (-3.55%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving MBIO Today?
No stock-specific AI insight has been generated for MBIO yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.53$3.68
$0.75
Fundamentals
Market Cap$6M
P/E Ratio—
EPS$-0.39
Dividend Yield—
Dividend / Share—
ROE-0.4%
Profit Margin—
Debt / Equity—
Trading
Volume28K
Avg Volume (10D)—
Shares Outstanding6.7M
MBIO News
3 articles- Cascade Prodrug Inc. Appoints Industry Veterans Manuel (Manny) Litchman and Andres Gutierrez to Board of DirectorsYahoo Finance·Aug 28, 2025
- Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and GlioblastomaYahoo Finance·Jul 7, 2025
- Wall Street Set to Open Lower Wednesday as Jobs Data Misses ForecastsYahoo Finance·Jul 2, 2025
All 3 articles loaded
Price Data
Open$0.75
Previous Close$0.77
Day High$0.78
Day Low$0.74
52 Week High$3.68
52 Week Low$0.53
52-Week Range
$0.53$3.68
$0.75
Fundamentals
Market Cap$6M
P/E Ratio—
EPS$-0.39
Dividend Yield—
Dividend / Share—
ROE-0.4%
Profit Margin—
Debt / Equity—
Trading
Volume28K
Avg Volume (10D)—
Shares Outstanding6.7M
About Mustang Bio Inc
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, is focused on translating medical advances in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. The company is headquartered in Worcester, Massachusetts.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—